Cas:1187385-96-1 4-(5-Bromo-4-methyl-2-pyridinyl)morpholine manufacturer & supplier

Chemical Name:4-(5-Bromo-4-methyl-2-pyridinyl)morpholine

CAS.NO:1187385-96-1

Synonyms:4-(5-bromo-4-methylpyridin-2-yl)morpholine;4-(5-Bromo-4-methyl-2-pyridinyl)morpholine;Morpholine, 4-(5-bromo-4-methyl-2-pyridinyl)-

Molecular Formula:C₁₀H₁₃BrN₂O

Molecular Weight:257.127

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:390.6±42.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.572

PSA:25.36000

Exact Mass:256.021118

LogP:1.93

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-(5-bromo-4-methylpyridin-2-yl)morpholine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Morpholine, 4-(5-bromo-4-methyl-2-pyridinyl)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(5-bromo-4-methylpyridin-2-yl)morpholine Use and application,4-(5-Bromo-4-methyl-2-pyridinyl)morpholine technical grade,usp/ep/jp grade.

Related News: A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge. 3-amino-3-methyl-5-{5-[5-(4-fluorophenyl)pentanoyl]thiophen-2-yl}pentylphosphonic acid manufacturers A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge. 2-[2-(2-oxonaphthalen-1-ylidene)hydrazinyl]naphthalene-1-sulfonic acid suppliers As a result, the team identified and prioritized studies that would provide the necessary product and process understanding needed to develop a control strategy, ensure the reproducibility of the product, and meet its intended safety, efficacy, stability, and performance profile regardless of the manufacturing scale. 1-(3-Phenylsulfanyl-propyl)-cyclopentanol vendor & factory Biogen’s Alzheimer’s drug, Aduhelm, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug.,A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge.